Menopause: Clinical Trials

32 trials for Menopause, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

32 completed. 32 Phase 3, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 332Completed 32
Phase 25Completed 5

Follow Menopause: new trials by email Literature Review of Menopause trials Research Report on Menopause

Trials (filtered) newest first · largest first

All 32 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Vaginal Health Trial
Vagifem, Replens, Placebo tablet - Atrophy of Vagina, Menopause
Phase 3CompletedFred Hutchinson Cancer Center3022016-04-012018-07-12
Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women
oral estradiol 1.0 mg, oral progesterone 100 mg - Menopause
Phase 3CompletedIntira Sriprasert202015-12-012020-03-19
Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women
Estradiol, Placebo - Vulvovaginal Atrophy, Menopause
Phase 3CompletedTherapeuticsMD7642014-09-012017-05-25
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
Estradiol, Progesterone, Placebo - Menopause
Phase 3CompletedTherapeuticsMD18452013-08-052019-05-06
Qing'E Formula Therapy on Menopausal Symptoms
Qing'E pills, Placebo - Menopause
Phase 2 / Phase 3CompletedShanghai University of Traditional Chinese Medicine2402013-03-012019-04-05
Therapy to Prevent Sexual Pain in Breast Cancer Survivors
Topical liquid lidocaine, Topical saline - Vulvodynia, Dyspareunia
Phase 3CompletedOHSU Knight Cancer Institute502011-12-012017-04-14
Perimenopausal Estrogen Replacement Therapy Study
Estradiol, Placebo - Perimenopause, Menopause
Phase 2 / Phase 3CompletedUniversity of North Carolina, Chapel Hill1722010-10-012017-08-22
Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer
Risedronate, Placebo - Breast Cancer, Menopause
Phase 3CompletedHospices Civils de Lyon202009-11-012013-10-31
Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis
bazedoxifene 20 mg/ conjugated estrogens 0.45 mg, bazedoxifene 20 mg/ conjugated estrogens 0.625 mg, bazedoxifene 20 mg - Menopause, Osteoporosis
Phase 3CompletedPfizer18862009-01-012014-04-08
Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women
Teriparatide (PTH 1-34) - Menopause, Fracture
Phase 2 / Phase 3CompletedColumbia University222008-08-202018-07-26
Efficacy and Safety of Estradiol and Progesterone Microspheres for the Treatment of Climacteric Symptoms.
Estradiol and Progesterone - Menopause
Phase 2 / Phase 3CompletedCentro A.F. de Estudios Tecnologicos, S.A.1032007-04-012009-08-25
Endometrial Safety of a Low Dose of VagifemĀ® in Postmenopausal Women With Atrophic Vaginitis
estradiol, 10 mcg - Menopause, Postmenopausal Vaginal Atrophy
Phase 3CompletedNovo Nordisk A/S3362007-01-012017-03-15
A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal Atrophy
DR-2041a, DR-2041b, Placebo - Menopause
Phase 3CompletedDuramed Research6222006-08-012015-04-20
Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal Women
Desvenlafaxine succinate sustained-release (DVS SR) - Menopause, Vasomotor System
Phase 3CompletedWyeth is now a wholly owned subsidiary of Pfizer4502006-06-012007-06-01
Study Evaluating DVS-233 SR for Treatment of Vasomotor Symptoms Associated With Menopause
DVS-233 - Menopause
Phase 3CompletedWyeth is now a wholly owned subsidiary of Pfizer4652005-04-012007-06-01
Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms
estradiol, 10 mcg - Menopause, Postmenopausal Vaginal Atrophy
Phase 3CompletedNovo Nordisk A/S3092005-03-012017-02-08
A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal Atrophy
Synthetic Conjugated estrogens, B, Placebo - Menopause
Phase 3CompletedDuramed Research3002004-11-012013-09-02
Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012)
esmirtazapine, Placebo - Menopause, Vasomotor Symptoms
Phase 3CompletedMerck Sharp & Dohme LLC9432004-10-152019-04-02
Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)
Esmirtazapine, Placebo - Postmenopausal Symptoms, Menopause
Phase 3CompletedMerck Sharp & Dohme LLC9462004-09-152019-04-02
Comparison of the Efficacy and Tolerability of Black Cohosh Vs Tibolone in Patients With Menopausal Symptoms
Black Cohosh (iCR) or tibolone - Menopause
Phase 3CompletedSchaper & Bruemmer GmbH & Co KG2402004-09-012006-03-06

Showing 20 of 32. Sign in to see all of them.

Narrower conditions

Hot Flashes (6)  ·  Osteoporosis (5)  ·  Bone Diseases, Metabolic (4)  ·  Dyspareunia (4)  ·  Breast Neoplasms (2)  ·  Blushing (1)  ·  Cardiovascular Diseases (1)  ·  Depression (1)  ·  Diabetes Mellitus (1)  ·  Fever (1)  ·  Fractures, Bone (1)  ·  Heart Diseases (1)  ·  Hypercholesterolemia (1)  ·  Hypertension (1)  ·  Obesity (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (8)  ·  Signs and Symptoms (8)  ·  Metabolic Diseases (6)  ·  Musculoskeletal Diseases (6)  ·  Nutritional and Metabolic Diseases (6)  ·  Bone Diseases (5)  ·  Mental Disorders (5)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Genital Diseases (4)  ·  Genital Diseases, Female (4)  ·  Genital Diseases, Male (4)  ·  Male Urogenital Diseases (4)  ·  Sexual Dysfunction, Physiological (4)  ·  Sexual Dysfunctions, Psychological (4)

Interventions

Estradiol (11)  ·  Progesterone (4)  ·  Estrogens, Conjugated (USP) (2)  ·  Medroxyprogesterone Acetate (2)  ·  Mirtazapine (2)  ·  Diet, Fat-Restricted (1)  ·  Estrogens (1)  ·  Gabapentin (1)  ·  Genistein (1)  ·  Klimadynon (1)  ·  Norethindrone Acetate (1)  ·  Parathyroid Hormone (1)  ·  Prempro (1)  ·  Progestins (1)  ·  Risedronic Acid (1)

Sponsors

Novo Nordisk A/S (5)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (3)  ·  Duramed Research (2)  ·  Merck Sharp & Dohme LLC (2)  ·  TherapeuticsMD (2)  ·  Bayer (1)  ·  Boehringer Ingelheim (1)  ·  Centro A.F. de Estudios Tecnologicos, S.A. (1)  ·  Columbia University (1)  ·  Fred Hutchinson Cancer Center (1)  ·  Hospices Civils de Lyon (1)  ·  Intira Sriprasert (1)  ·  Karolinska University Hospital (1)  ·  Mahidol University (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)

Countries

United States (13)  ·  Finland (5)  ·  France (4)  ·  Sweden (4)  ·  Belgium (3)  ·  Canada (3)  ·  Denmark (3)  ·  Hungary (3)  ·  Mexico (3)  ·  Norway (3)  ·  United Kingdom (3)  ·  China (2)  ·  Czechia (2)  ·  Netherlands (2)  ·  Poland (2)

Top investigators

Adi Cohen, MD (1)  ·  Andrea Z LaCroix, PhD (1)  ·  Caroline Mitchell, MD, MPH (1)  ·  David F Archer, MD (1)  ·  Debra Butt, MSc MD CCFP (1)  ·  Elizabeth Shane, MD (1)  ·  Francesco Squadrito, MD (1)  ·  Karolina Kublickiene, MD PhD (1)  ·  Katherine A Guthrie, PhD (1)

Results publications

PMID 18165394, PMID 18978105, PMID 20859151, PMID 30712391, PMID 17453860, PMID 17487652, PMID 17577003, PMID 1791769, PMID 18053998, PMID 18178111, PMID 18202966, PMID 19252451, PMID 20888118, PMID 21824950, PMID 23635731, PMID 24438370, PMID 24807329, PMID 25835751, PMID 26215946, PMID 27187320, PMID 28355090, PMID 29322164, PMID 29554173, PMID 29738424, PMID 29889748, PMID 30238814, PMID 30586005, PMID 30601452, PMID 30994576, PMID 31364889, PMID 31688572, PMID 31838497, PMID 31913228, PMID 32706883, PMID 32740481, PMID 32932401, PMID 33038141, PMID 33110039, PMID 33288437, PMID 33367735, PMID 33675793, PMID 34054104, PMID 35213517, PMID 35353163, PMID 36374501, PMID 37402281, PMID 37619252, PMID 38979716

NIH funding

2004 (2), R01AR048932 (1), R01HL045167 (1), R01MH087619 (1)